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1  | INTRODUC TION
Prosthodontic	treatment	assisted	by	dental	implants	has	continued	
to	evolve	and	 is	a	 routine	option	for	clinicians	and	patients.	There	
are,	however,	questions	that	remain	for	newer	treatment	protocols.
For	 treatment	of	edentulous	arches,	 the	appropriate	number	of	
implants	required	to	support	a	prosthesis	and	the	influence	of	implant	
inclination	 remain	 controversial.	 Systematic	 reviews	 conducted	 by	
Polido	et	al.	and	by	Lin	and	Eckert	analysed	and	compared	the	implant	
number	and	inclination,	respectively.	For	partially	dentate	(or	eden-
tate)	 arches,	 placement	 and	 loading	 protocols	 continue	 to	 develop.	
Subsequent	to	a	systematic	review	of	the	existing	 literature	on	this	
topic,	Gallucci	et	al.	consider	the	state	of	the	science,	and	propose	a	
comprehensive	classification	and	treatment	philosophy	that	considers	
placement	and	loading	as	a	singular	planning	and	treatment	decision.
Material	 options	 continue	 to	 expand	 for	 fabrication	 of	 both	
dental	 implants	 and	 prostheses.	 A	 systematic	 review	 conducted	
by	Roehling	 et	al.	 investigated	 the	 state	 of	 the	 science	 associated	
with	dental	implants	fabricated	from	zirconia	and	compared	the	per-
formance	of	zirconia	implants	with	those	fabricated	from	titanium.	
Systematic	reviews	by	Pjetursson	et	al.,	and	Sailer	et	al.	analysed	the	
performance	of	zirconia	ceramic	when	compared	to	metal	ceramic	
restorative	materials	for	the	restoration	of	implants	in	single	tooth	
sites	and	extended	edentulous	spans,	respectively.
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Abstract
Objectives:	Working	Group	2	was	convened	to	address	topics	relevant	to	prostho-
dontics	 and	 dental	 implants.	 Systematic	 reviews	were	 developed	 according	 to	 fo-
cused	 questions	 addressing	 (a)	 the	 number	 of	 implants	 required	 to	 support	 fixed	
full-	arch	 restorations,	 (b)	 the	 influence	of	 intentionally	 tilted	 implants	compared	to	
axial	positioned	implants	when	supporting	fixed	dental	prostheses	(FDPs),	(c)	implant	
placement	and	loading	protocols,	(d)	zirconia	dental	implants,	(e)	zirconia	and	metal	
ceramic	implant	supported	single	crowns	and	(f)	zirconia	and	metal	ceramic	implant	
supported	FDPs.
Materials and methods:	Group	2	considered	and	discussed	information	gathered	in	
six	systematic	 reviews.	Group	participants	discussed	statements	developed	by	 the	
authors	 and	developed	consensus.	The	group	developed	and	 found	consensus	 for	
clinical	recommendations	based	on	both	the	statements	and	the	experience	of	the	
group.	The	consensus	statements	and	clinical	recommendations	were	presented	to	
the	plenary	(gathering	of	all	conference	attendees)	and	discussed.	Final	versions	were	
developed	after	consensus	was	reached.
Results:	A	total	of	27	consensus	statements	were	developed	from	the	systematic	re-
views.	Additionally,	the	group	developed	24	clinical	recommendations	based	on	the	
combined	expertise	of	the	participants	and	the	developed	consensus	statements.
Conclusions:	The	literature	supports	the	use	of	various	implant	numbers	to	support	
full-	arch	fixed	prostheses.	The	use	of	intentionally	tilted	dental	implants	is	indicated	
when	appropriate	conditions	exist.	Implant	placement	and	loading	protocols	should	
be	considered	together	when	planning	and	treating	patients.	One-	piece	zirconia	den-
tal	implants	can	be	recommended	when	appropriate	clinical	conditions	exist	although	
two-	piece	zirconia	 implants	 should	be	used	with	caution	as	a	 result	of	 insufficient	
data.	Clinical	 performance	of	 zirconia	 and	metal	 ceramic	 single	 implant	 supported	
crowns	is	similar	and	each	demonstrates	significant,	though	different,	complications.	
Zirconia	ceramic	FDPs	are	less	reliable	than	metal	ceramic.	Implant	supported	mono-
lithic	zirconia	prostheses	may	be	a	future	option	with	more	supporting	evidence.
K E Y W O R D S
ceramic	crown,	ceramic	fixed	dental	prosthesis,	full-arch	prosthesis,	implant	loading,	implant	
number,	implant	placement,	implant	survival,	patient	outcomes,	tilted	implants,	zirconia	
implants
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When	developing	consensus	statements,	the	group	chose	to	in-
clude	the	number	and	type	of	citations	from	which	conclusions	were	
drawn	for	the	benefit	of	the	reader.
The	six	systematic	reviews	undertaken	by	this	group	include:
1	 Clinical	performance	of	intentionally	tilted	implants	versus	axially	
positioned	implants:	A	systematic	review.
Wei-	Shao	Lin	and	Steven	E.	Eckert.
2	 Implant	placement	and	 loading	protocols	 in	partially	edentulous	
patients:	A	systematic	review.
	German	O.	Gallucci,	Adam	Hamilton,	Wenjie	Zhou,	Daniel	Buser	
and	Stephen	Chen.
3	 Performance	and	outcomes	of	zirconia	dental	implants	in	clinical	
studies:	A	meta-analysis.
	Stefan	 Roehling,	 Karl	 A.	 Schlegel,	 Henriette	 Woelfler	 and	
Michael	Gahlert.
4 Number	of	 implants	placed	 for	complete	arch	 fixed	prostheses:	
A	 systematic	 review	 and	 meta-analysis.
	Waldemar	 Daudt	 Polido,	 Tara	 Aghaloo,	 Thomas	 W.	 Emmett,	
Thomas	D.	Taylor	and	Dean	Morton.
5	 A	 systematic	 review	 of	 the	 survival	 and	 complication	 rates	 of	
zirconia-ceramic	 and	 metal-ceramic	 multiple-unit	 fixed	 dental	
prostheses.
	Irena	 Sailer,	 Malin	 Strasding,	 Nicola	 Alberto	 Valente,	 Marcel	
Zwahlen,	Shiming	Liu	and	Bjarni	Elvar	Pjetursson.
6	 A	 systematic	 review	 of	 the	 survival	 and	 complication	 rates	 of	
	zirconia-ceramic	and	metal-ceramic	single	crowns.
	Bjarni	 E.	 Pjetursson,	 Nicola	 A.	 Valente,	 Malin	 Strasding,	 Marcel	
Zwahlen,	Shiming	Liu	and	Irena	Sailer.
1.1 | Disclosures
All	participants	were	asked	to	disclose	any	possible	conflicts	of	inter-
est	 that	could	potentially	 influence	 the	direction	of	 the	consensus	
deliberations.	No	conflicts	of	interest	were	identified.
2  | NUMBER OF IMPL ANTS PL ACED FOR 
COMPLETE ARCH FIXED PROSTHESES:  A 
SYSTEMATIC RE VIE W AND META- ANALYSIS
2.1 | Preamble
Varying	numbers	of	implants	have	been	reported	in	the	literature	as	being	
used	to	supported	fixed	full-	arch	prostheses	for	completely	edentulous	
arches.	Many	factors	are	reported	to	influence	the	decision	regarding	
the	number	if	implants	chosen.	This	systematic	review	was	designed	to	
evaluate	surgical	and	prosthetic	outcomes	associated	with	five	or	more	
implants,	and	compare	these	with	using	less	than	five	implants,	when	
providing	full-	arch	fixed	prostheses	for	completely	edentulous	arches.	
Primary	 outcomes	 investigated	were	 implant	 and	 prosthesis	 survival.	
Secondary	outcomes	included	distribution	of	implants,	implant	inclina-
tion,	loading	protocol	and	mode	of	prosthesis	retention.
2.2 | Consensus statements
1. There	is	no	statistically	significant	difference	in	 implant	survival	
rates	associated	with	 the	use	of	 fewer	 than	 five	 implants	when	
compared	 to	 five	 or	 more	 implants	 when	 supporting	 a	 fixed	
dental	prosthesis.	This	statement	is	based	on	outcomes	reported	
in	 93	 studies	 (9	 RCTs,	 42	 Prospective	 and	 42	 Retrospective)	
with	 a	 median	 follow-up	 of	 8	years	 (range:	 1–15	years).
2. There	 is	 no	 statistically	 significant	difference	 in	outcomes	 (im-
plant	 and	 prosthesis	 survival)	 for	 full-arch	 FDPs	 in	 the	maxilla	
supported	 by	 fewer	 than	 five	 implants	 (median	 follow-up	 of	
5.5	years)	when	compared	to	five	or	more	implants	(median	fol-
low-up	of	8	years).	This	statement	is	based	on	the	analysis	of	data	
from	50	groups	of	patients,	extracted	from	the	28	studies	that	
reported	 numbers	 of	 implants	 for	 the	 maxilla	 (1	 RCT,	 13	
Prospective	and	14	retrospective),	and	from	the	19	papers	that	
reported	 for	 both	 groups	 (3	 RCT,	 7	 Prospective	 and	 9	
Retrospective),	among	which	26	reported	on	fewer	than	five	im-
plants,	and	24	reported	on	five	or	more	implants.	In	all,	47	publi-
cations	reported	outcomes	for	the	maxilla	(4	RCTs,	20	Prospective	
and	23	Retrospective).	Of	the	26	studies	documenting	outcomes	
for	fewer	than	five	implants,	the	majority	reported	on	the	use	of	
four	implants	incorporating	distally	tilted	posterior	implants	and	
an	immediate	loading	protocol	(23	reports	with	a	median	follow-
up	of	5.5	years).	A	majority	of	the	24	studies	documenting	out-
comes	 for	 five	 or	 more	 implants	 reported	 use	 of	 six	 implants	
positioned	in	a	parallel	configuration	and	utilizing	an	immediate	
loading	protocol	(20	reports	with	a	median	follow-up	of	8	years).
3. There	 is	no	statistically	significant	difference	(p	<	0.05)	 in	out-
comes	(implant	and	prosthesis	survival)	for	full-arch	FDPs	in	the	
mandible	supported	by	 less	than	five	 implants	 (median	follow-
up	of	5.5	years)	when	compared	to	five	or	more	implants	 (me-
dian	 follow-up	 of	 5.5	years).	 This	 statement	 is	 based	 on	 the	
analysis	of	data	from	72	groups,	among	which	58	reported	on	
fewer	than	five	implants	and	14	reported	on	five	or	more.	Data	
were	extracted	from	65	publications	that	reported	on	the	man-
dible	 (8	RCT,	29	Prospective	and	28	Retrospective).	Of	the	14	
studies	documenting	use	of	five	or	more	implants	to	support	a	
complete	arch	prosthesis	 in	the	mandible,	a	majority	used	five	
implants	 (10	 reports	with	 a	median	 follow-up	 of	 4	years)	 in	 a	
parallel	configuration	(12	reports)	and	with	an	immediate	load-
ing	protocol	(8	reports).	Of	the	58	studies	documenting	use	of	
fewer	than	five	implants,	a	majority	used	four	implants	(41	stud-
ies	 with	 a	 median	 follow-up	 of	 5.5	years	 and	 a	 range	 of	
1–10	years).	A	parallel	configuration	was	reported	in	27	papers	
and	use	of	posterior	distally	inclined	implants	reported	in	31.	An	
immediate	loading	protocol	was	reported	as	being	used	in	48	of	
the	58	articles.
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2.3 | Clinical recommendations
1. The	final	prosthetic	plan	should	be	considered	when	developing	
a	 surgical	 plan	 for	 implant	 treatment	 of	 edentulous	 arches.	
Factors	 to	 be	 considered	 include:	
a.	 Prosthesis	material
b.	 One-piece	or	segmented	prostheses
c.	 Aesthetic	factors	(e.g.,	lip	support,	smile	line)
d.	 Condition	of	the	opposing	dentition
e.	 Available	space	for	the	prosthesis
f.	 Anatomy	of	the	edentulous	ridge	(maxilla,	mandible,	bone	vol-
ume	and	quality,	anatomic	limitations)
g.	 Planned	 implant	distribution	 (AP	distribution)	 and	 cantilever	
length
h.	 Space	available	for	hygiene	and	maintenance
i.	 Patient	preference	and	compliance
2. When	patients	present	with	teeth	 in	place,	all	 treatment	options	
should	be	considered	as	part	of	the	informed	consent	process	and	
appropriate	consideration	should	be	given	to	preservation	of	teeth.	
When	the	decision	is	made	to	rehabilitate	the	patient	with	a	full-
arch	prosthesis,	and	tooth	extraction	is	required,	planning	consid-
eration	must	be	given	to	the	space	required	for	the	prosthesis	in	all	
dimensions.
3. A	minimum	number	of	four	appropriately	distributed	implants	are	
recommended	to	support	a	one-piece	full-arch	fixed	prosthesis.	
However,	 the	 impact	 of	 future	 implant	 loss/complications	 on	
prosthesis	support	should	be	considered	when	choosing	implant	
number.	 Additional	 implants	 can	 provide	 options	 for	 fixed	 full-
arch	segmented	prostheses.
4. When	selecting	the	placement	and	loading	protocol,	the	following	
conditions	should	be	considered:	
a.	 Systemic	conditions
b.	 Implant	stability	(insertion	torque/ISQ)
c.	 The	need	for	bone	grafting	at	the	time	of	placement
d.	 Implant	size	and	shape
e.	 Experience	and	skill	of	the	clinician
These	modifiers	should	be	considered	for	each	site	where	an
	implant	is	planned.
5. As	part	of	a	comprehensive	plan,	and	when	clinician	skill	and	oral	
environment	are	favourable,	 the	 invasiveness	of	surgery	can	be	
reduced	 through	 utilization	 of	 improved	 implant	materials,	 sur-
faces	and	designs	(short,	narrow,	tapered),	prosthetic	connections	
and	placement	options	(tilted	implants).
6. Bone	augmentation	is	recommended	when	there	is	a	need	to	in-
crease	 implant	 distribution	 or	 number	 in	 response	 to	 the	 pros-
thetic	plan.	These	procedures	are	more	invasive	and	challenging,	
increasing	the	level	of	clinician	skill	and	experience	required.
2.4 | Recommendations for future research
1. There	 is	 a	 need	 for	 additional	 randomized	 clinical	 trials	 com-
paring	 use	 of	 four	 and	 six	 implants	 for	 support	 of	 fixed	 full-
arch	 prostheses.
2. Studies	comparing	one-piece	and	segmented	prostheses	for	the	
rehabilitation	of	edentulous	arches	are	required.
3. Studies	 evaluating	 the	 influence	 of	 digital	 planning	 and	 guided	
surgical	options	on	treatment	predictability	and	patient	outcomes	
are	required.
4. Studies	evaluating	the	influence	of	intraoral	optical	scanning	and	
the	use	of	CAD-CAM	technology	on	full-arch	prosthesis	fit	and	
patient	outcomes	are	required.
5. There	is	a	need	for	research	evaluating	the	use	of	reduced	diam-
eter,	short	and	extra-short	implants	when	planning	and	treatment	
edentulous	arches	with	full-arch	prostheses.	Randomized	clinical	
trials	comparing	outcomes	for	these	with	four	implants	including	
tilted	options	are	needed.
3  | CLINIC AL PERFORMANCE OF 
INTENTIONALLY TILTED IMPL ANTS VERSUS 
A XIALLY POSITIONED IMPL ANTS
3.1 | Preamble
A	 treatment	 approach	using	 intentionally	 tilted	 implants	 has	 been	
recommended	to	both	reduce	prosthetic	cantilevers	and	additional	
surgical	interventions.	This	review	was	undertaken	to	determine	the	
clinical	performance	of	dental	 implants	that	are	 intentionally	tilted	
when	compared	to	implants	that	are	placed	following	the	long	axis	
of	the	residual	alveolar	ridge,	when	used	to	support	full-	arch	fixed	
prostheses.	 Primary	 outcomes	 evaluated	 were	 implant	 and	 pros-
thesis	 survival	 rates.	 Secondary	 outcomes	 included	 peri-	implant	
marginal	 bone	 loss,	 soft	 and	 hard	 tissue	 complications,	 prosthetic	
complications	and	subjective	patient-	centred	outcomes.
3.2 | Consensus statements
1. There	 is	 no	 statistically	 significant	 difference	 in	 primary	
outcomes	 (survival	 rates	 for	 implant	 and	 prosthesis)	 or	 sec-
ondary	 outcomes	 (peri-implant	 marginal	 bone	 loss,	 soft	 and	
hard	 tissue	 complications,	 prosthetic	 complications	 and	 pa-
tient-centred	 outcomes)	 for	 implants	 placed	 in	 an	 axial	 or	
in	a	tilted	configuration	when	used	to	support	full-arch	FDPs.	
This	 statement	 is	 based	 on	 20	 studies	 (2	 RCTs,	 1	 CT	 and	
17	 Prospective	 Cohort).
2. The	 most	 common	 complications	 associated	 with	 an	 interim	
full-arch	fixed	acrylic	resin	prosthesis	were	prosthesis	fracture,	
screw	 loosening	 and	 fracture	 of	 the	 veneering	material.	 This	
statement	 is	 based	 on	 20	 studies	 (2	 RCTs,	 1	 CT	 and	 17	
Prospective	Cohort).
3. For	 definitive	 prostheses,	metal	 framework	 fracture	was	 un-
common.	More	commonly	encountered	complications	included	
wear	 or	 fracture	 of	 the	 veneering	material	 or	 artificial	 teeth,	
need	for	re-adaptation	of	prostheses	to	tissue	to	compensate	
for	 continuing	 resorption,	 abutment	 or	 prosthetic	 screw	
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loosening,	prosthetic	screw	fracture	and	 loss	of	screw	access	
restoration.	This	statement	 is	based	on	21	studies	 (2	RCTs,	1	
CT	and	18	Prospective	Cohort).
4. The	studies	report	satisfactory	patient-reported	outcomes	meas-
ures.	These	 include	aesthetics,	phonetics,	ease	of	maintenance	
and	functional	efficiency.	This	statement	is	based	on	nine	studies	
(1	RCT,	8	Prospective	Cohort).
3.3 | Clinical recommendations
1. The	anterior	posterior	implant	distribution	should	be	maximized	
for	 full-arch	 FDPs.	When	 conditions	 allow	 implants	 should	 be	
positioned	 axially.	 If	 anatomic	 limitations	 or	 prosthetic	 indica-
tions	 exist,	 the	 posterior	 implants	 can	 be	 intentionally	 tilted.
3.4 | Recommendations for future research
1. Direct	 randomized	 controlled	 clinical	 trials	 or	 non-randomized	
comparative	 cohort	 studies	 with	 longer	 follow-up	 periods	 and	
larger	 study	 populations	 should	 be	 designed	 to	 specifically	
address	 the	 questions	 of	 implant	 and	 prosthesis	 performance	
when	 using	 intentionally	 tilted	 or	 axially	 placed	 implants	 to	
support	 full-arch	 FDPs.
4  | IMPL ANT PL ACEMENT AND LOADING 
PROTOCOL S.  A SYSTEMATIC RE VIE W
4.1 | Preamble
This	 systematic	 review	 evaluated	 the	 scientific	 evidence	 relat-
ing	 to	post-	extraction	 implant	placement	 and	 timing	 and	 loading	
protocols	combined.	A	validation	tool	was	used	to	determine	the	
level	of	scientific	and	clinical	documentation	for	each	combination	
of	implant	placement	and	loading	protocols	(Gallucci	et	al.,	2009).	
Furthermore,	 patient-	 and	 site-	specific	 criteria	 for	 selecting	 the	
placement	 and	 loading	 protocols	 were	 tabulated	 to	 formulate	
clinical	 recommendations.	Due	to	the	heterogenicity	of	 the	data,	
meta-	analysis	was	not	possible;	however,	descriptive	analysis	was	
completed.
4.2 | Definition of terms as described in: 
Implant placement and loading protocols. A 
systematic review
German	Gallucci,	Adam	Hamilton,	Wenjie	 Zhou,	Daniel	Buser	 and	
Stephen	Chen.
Type	1A:	Immediate	placement	plus	immediate	restoration/loading
Type	1B:	Immediate	placement	plus	early	loading
Type	1C:	Immediate	placement	plus	conventional	loading
Type	2A:	 Early	 placement	with	 soft	 tissue	 healing	 plus	 immediate	
restoration/loading
Type	2B:	Early	placement	with	soft	tissue	healing	plus	early	loading
Type	2C:	Early	placement	with	soft	tissue	healing	plus	conventional	
loading
Type	3A:	Early	placement	with	partial	bone	healing	plus	immediate	
restoration/loading
Type	3B:	Early	placement	with	partial	bone	healing	plus	early	loading
Type	 3C:	 Early	 placement	 with	 partial	 bone	 healing	 plus	 conven-
tional	loading
Type	4A:	Late	placement	plus	immediate	restoration/loading
Type	4B:	Late	placement	plus	early	loading
Type	4C:	Late	placement	plus	conventional	loading
Due	to	the	limitations	in	distinct	specification	of	the	implant	place-
ment	time	in	many	clinical	studies	reported,	the	early	 implant	place-
ment	groups	(types	2	and	3)	were	combined	for	each	loading	protocol	
(Type	2/3A,	Type	2/3B	and	Type	2/3C).
Implant	Placement	protocols	were	defined	as	follows:
a.	 Immediate	implant	placement:	Dental	implants	are	placed	in	the	
socket	on	the	same	day	as	tooth	extraction.
b.	Early	implant	placement:	Dental	implants	are	placed	with	soft	tis-
sue	healing	(4–8	weeks)	or	with	partial	bone	healing	(12–16	weeks)	
after	tooth	extraction.
c.	 Late	 implant	 placement:	 Dental	 implants	 are	 placed	 after	 com-
plete	bone	healing,	more	than	6	months	after	tooth	extraction.
Implant	loading	protocols	were	defined	as	follows:
a.	 Immediate	loading:	Dental	implants	are	connected	to	a	prosthesis	
in	occlusion	with	the	opposing	arch	within	1	week	subsequent	to	
implant	placement.
b.	 Immediate	restoration:	Dental	implants	are	connected	to	a	pros-
thesis	held	out	of	occlusion	with	the	opposing	arch	within	1	week	
subsequent	to	implant	placement.
c.	 Early	loading:	Dental	implants	are	connected	to	the	prosthesis	be-
tween	1	week	and	2	months	after	implant	placement.
d.	Conventional	 loading:	Dental	 implants	are	allowed	a	healing	pe-
riod	of	more	than	2	months	after	implant	placement	with	no	con-
nection	of	the	prosthesis.
4.3 | Consensus statements
1. The	 newly	 proposed	 classification	 assessing	 both	 the	 timing	
of	 implant	placement	and	 loading	combinations	allows	for	com-
prehensive	 treatment	 selection.
2. a.		Type	 1A	 (immediate	 placement	 plus	 immediate	 restoration/
loading)	is	a	clinically	documented	protocol.	The	survival	rate	
was	98%	(median	100,	range	87%–100%).
b.	Type	1B	(immediate	placement	plus	early	loading)	is	a	clinically	
documented	protocol.	The	survival	rate	was	98%	(median	100,	
range	93%–100%).
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c.	Type	1C	(immediate	placement	plus	conventional	loading)	is	a	
scientifically	and	clinically	valid	protocol.	The	survival	rate	was	
96%	(median	99,	range	91%–100%).
3. a.		Type	2-3A	(early	placement	plus	 immediate	restoration/load-
ing)	presents	clinically	insufficient	documentation.
b.	Type	2-3B	(early	placement	plus	early	loading)	presents	clini-
cally	insufficient	documentation.
c.	Type	2-3C	(early	placement	plus	conventional	loading)	is	a	sci-
entifically	and	clinically	valid	protocol.	The	survival	 rate	was	
96%	(median	96,	range	91%–100%).
4. a.		Type	4A	(late	placement	plus	immediate	restoration/loading)	is	
a	 clinically	 documented	protocol.	 The	 survival	 rate	was	98%	
(median	99,	range	83%–100%).
b.	Type	4B	 (late	placement	plus	early	 loading)	 is	a	 scientifically	
and	clinically	valid	protocol.	The	survival	 rate	was	98%	 (me-
dian	99,	range	97%–100%).
c.	Type	4C	(immediate	placement	plus	conventional	loading)	is	a	
scientifically	and	clinically	valid	protocol.	The	survival	rate	was	
98%	(median	100,	range	95%–100%).
5. When	considering	placement/loading	protocols,	there	are	factors	
that	 can	 prevent	 the	 accomplishing	 of	 the	 intended	 treatment.	
These	factors	include:	
a.	 Patient-related	factors.
b.	 Lack	of	primary	stability.
c.	 The	need	for	bone	augmentation.
4.4 | Clinical recommendations
1. Treatment	 planning	 for	 implant	 therapy	 should	 commence	 once	
the	 indication	 for	 tooth	 extraction	 has	 been	 confirmed.	 Both	
the	 implant	 placement	 and	 loading	 protocol	 should	 be	 planned	
prior	to	tooth	extraction.	The	selection	of	the	implant	placement	
and	 restoration/loading	 protocol	 should	 be	 based	 on	 achieving	
predictable	 outcomes:	
a.	 Long-term	hard	and	soft	tissue	stability.
b.	 Optimal	aesthetics.
c.	 Reduced	risk	for	complications.
d.	Meet	patient-specific	and	site-related	criteria.
2. As	part	of	the	planning	and	consent	process,	alternative	treat-
ment	modalities	 should	be	 in	 place,	 in	 the	 event	 that	 specific	
intra-operative	procedural	criteria	are	not	met.	 Implant	place-
ment	and	restoration/loading	protocols	present	with	different	
levels	of	clinical	difficulty	and	overall	treatment	risk.	When	se-
lecting	 treatment	 modalities,	 clinician	 skill	 and	 experience	
should	 match	 the	 challenges	 associated	 with	 the	 selected	
protocol.
3. The	implant	placement	and	loading	protocol	can	have	a	nega-
tive	impact	on	survival	and	success	of	specific	selection	criteria	
are	 not	met,	 and/or	 execution	 of	 the	 clinical	 procedure	 is	 of	
insufficient	 quality.	 Careful	 consideration	 of	 patient-centred	
benefits	of	the	different	implant	placement	and	loading	proto-
cols	 and	 the	 associated	 risks	 should	 be	 taken	 into	
consideration.
4. Immediate	 placement	 and	 immediate	 restoration/loading	 (type	
1A)	is	a	complex	surgical	and	prosthodontic	procedure	and	should	
only	be	performed	by	clinicians	with	a	high	 level	of	clinical	skill	
and	 experience.	 Type	 1A	 protocol	 should	 only	 be	 considered	
when	 there	 are	 patient-centred	 advantages	 (e.g.,	 aesthetic	 re-
quirements,	reduced	morbidity),	and	when	the	following	clinical	
conditions	are	met:	
a.	 Intact	socket	walls.
b.	 Facial	bone	wall	at	least	1	mm	in	thickness.
c.	 Thick	soft	tissue.
d.	 No	acute	infection	at	the	site.
e.	 The	availability	of	bone	apical	and	lingual	to	the	socket	to	pro-
vide	primary	stability.
f.	 Insertion	torque	25–40	Ncm	and/or	ISQ	value	>70.
g.	 An	occlusal	scheme	which	allows	for	protection	of	the	provi-
sional	restoration	during	function.
h.	 Patient	compliance.
5. Early	implant	placement	may	be	considered	in	most	clinical	situa-
tions,	such	as	sites	with	thin	facial	walls	and	defects,	often	requir-
ing	 simultaneous	 bone	 augmentation	 procedures.	 Conventional	
loading	(type	2-3C)	is	well	documented	and	is	recommended	with	
early	 implant	 placement.	 Immediate	 (type	 2-3A)	 and	 early	 (type	
2-3B)	 loading	 protocols	 combined	with	 early	 implant	 placement	
are	not	sufficiently	well	documented	to	be	recommended	as	rou-
tine	procedures.
6. As	a	planned	procedure,	late	implant	placement	is	the	least	desir-
able	 of	 the	 placement	 time	 options,	 due	 to	 the	 risk	 of	 alveolar	
ridge	 resorption	 and	 reduction	 in	 bone	 volume,	 as	 well	 as	 ex-
tended	treatment	time.	When	late	placement	is	indication	for	pa-
tient-	 or	 site-related	 reasons,	 an	 alveolar	 ridge	 preservation	
procedure	is	recommended.
7. In	the	case	of	late	implant	placement,	early	loading	(type	4B)	and	
conventional	 loading	 (type	 4C)	 are	 well-documented	 protocols	
and	may	be	considered	routine.	Late	implant	placement	with	im-
mediate	loading	(type	4A)	may	be	considered	when	patient-cen-
tred	 advantages	 are	 present,	 and	 the	 criteria	 for	 immediate	
restoration/loading	are	met.
4.5 | Recommendations for future research
1. For	 future	 research	 in	 placement/loading	 protocols,	 it	 is	 recom-
mended	 that	 “Intention	 to	 treat”	 analyses	 are	 conducted	 and	
intention	 to	 treat	 considered	 as	 a	 primary	 outcome	 measure.
2. Due	to	the	possible	negative	influence	of	the	implant	placement/
loading	protocols	on	the	treatment	outcomes,	in	the	absence	of	
meeting	specific	criteria,	randomization	at	the	level	of	the	chosen	
treatment	is	not	recommended.
3. Future	research	on	implant	placement/loading	protocols	 is	re-
quired	with	well-designed	prospective	case	series	with	at	least	
5-year	 follow-up,	which	 should	 report	on	both	 the	placement	
and	loading	protocols.	The	specific	indications,	locations,	selec-
tion	criteria	and	aesthetic	parameters	for	the	different	types	of	
implant	placement	and	loading	should	also	be	reported.
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5  | PERFORMANCE AND OUTCOMES OF 
ZIRCONIA DENTAL IMPL ANTS
5.1 | Preamble
In	recent	history	(since	2000s),	numerous	zirconia	implant	types	ex-
hibiting	different	physical	 properties	 and	designs	have	been	 intro-
duced	to	the	dental	market.	This	systematic	review	was	undertaken	
to	 evaluate	 the	performance	of	 these	 implants.	 Primary	outcomes	
investigated	 included	 implant	 survival	 and	 peri-	implant	 marginal	
bone	loss.	Secondary	outcomes	included	implant	fractures,	technical	
complications,	biologic	complications	and	aesthetic	outcomes.	Upon	
review	of	the	literature,	it	became	apparent	that	the	data	should	be	
classified	 into	 two	 separate	 groups,	 those	 currently	 commercially	
available	(CA),	and	those	no	longer	commercially	available	(NCA).
5.2 | Consensus statements
1. The	 published	 data	 for	 CA	 zirconia	 implants	 only	 allow	 valid	
statements	 for	 one-piece	 designs.	 This	 statement	 is	 based	 on	
nine	clinical	studies	(8	Prospective	and	1	Retrospective)	including	
510	 implants	 followed	 for	 1-year,	 and	 five	 clinical	 studies	 (5	
Prospective)	 including	 192	 implants	 followed	 for	 2	years.
2. Comparing	survival	rates	of	CA	one-piece	zirconia	implants	with	
published	 data	 on	 titanium	 implants,	 1-year	 (98%)	 and	 2-year	
(97%)	results	showed	similar	outcomes.	This	statement	 is	based	
on	nine	clinical	studies	(8	Prospective	and	1	Retrospective)	includ-
ing	510	 implants	 followed	 for	1	year,	and	 five	clinical	 studies	 (5	
Prospective)	including	192	implants	followed	for	2	years.
3. The	survival	rates	of	CA	one-piece	zirconia	implants	are	statisti-
cally	 significantly	 higher	 than	 NCA	 implants.	 This	 statement	 is	
based	on	18	clinical	studies	(14	Prospective	and	4	Retrospective)	
including	1,128	implants.
4. CA	zirconia	implants	show	a	mean	peri-implant	marginal	bone	loss	
on	0.67	mm	(range:	0.20–1.02	mm)	after	1	year.	This	statement	is	
based	on	seven	clinical	studies	(6	Prospective	and	1	Retrospective)	
including	376	implants.
5. Comparing	NCA	and	CA	zirconia	implants,	marginal	bone	loss	is	
not	statistically	significantly	different.	This	statement	is	based	on	
14	clinical	studies	(11	Prospective	and	3	Retrospective)	including	
839	implants.
6. Comparing	NCA	and	CA	zirconia	implants,	the	fracture	rate	of	one-
piece	designs	has	 reduced	 from	3.4%	to	0.2%.	This	 statement	 is	
based	on	18	clinical	studies	(14	Prospective	and	4	Retrospective)	
including	1,128	implants.
5.3 | Clinical recommendations
1. Based	 on	 available	 data	 (up	 to	 2	years),	 the	 use	 of	 one-piece	
CA	 zirconia	 implants	 can	 be	 recommended	 in	 cases	 where	 a	
one-piece	 soft	 tissue	 level	 implant	with	 a	 cemented	 prosthesis	
in	 indicated	 and	 if	 requested	 by	 the	 patient.
2. Placement	of	one-piece	zirconia	implants	should	be	prosthetically	
driven	according	to	established	guidelines	for	the	implant	design.
3. When	using	one-piece	CA	zirconia	implants,	the	difficulties	relat-
ing	to	a	submucosal	prosthodontic	margin,	removal	of	cement	ex-
cess	and	difficulty	with	explantation	have	to	be	considered.
4. Two-piece	CA	zirconia	implants	can	only	be	recommended	with	
caution	due	to	insufficient	supporting	data.
5.4 | Recommendations for future research
1. More	data	and	clinical	studies	are	needed	regarding	the	clinical	
mid-	 and	 long-term	 performance	 of	 CA	 (2nd	 generation)	 one-
piece	 zirconia	 implants.
2. More	clinical	studies	focusing	on	CA	(2nd	generation)	two-piece	
zirconia	implants	are	needed	to	provide	support	for	use	as	an	al-
ternative	 to	 the	 limited	 indications	 given	 for	 the	 one-piece	 im-
plant	design.
6 | SURVIVAL AND COMPLICATION RATES 
OF ZIRCONIA CERAMIC AND METAL CERAMIC 
SINGLE IMPLANT SUPPORTED CROWNS
6.1 | Preamble
The	 aim	 of	 this	 systematic	 review	was	 to	 evaluate	 the	 available	
scientific	evidence	on	 the	 survival	 and	complication	 rates	of	ve-
neered	zirconia	ceramic	crowns	when	compared	to	metal	ceramic	
implant	 supported	 crowns.	 The	 primary	 outcome	 of	 this	 review	
was	the	comparison	of	the	survival	rates	of	the	veneered	zirconia	
and	metal	 ceramic	 crowns.	 Secondary	 outcomes	 reviewed	were	
biological	 complication	 rates,	 technical	 complication	 rates	 and	
aesthetic	failure	rates.
6.2 | Consensus statements
1. Zirconia	 ceramic	 and	 metal	 ceramic	 implants	 supported	 SCs	
exhibit	 similar	 5-year	 survival	 rates.	 This	 applies	 to	 both	 an-
terior	 and	 posterior	 regions.	 This	 statement	 is	 based	 on	 36	
clinical	 trials	 (22	 Prospective,	 14	 Retrospective),	 reporting	 on	
4,363	implant	supported	metal	ceramic	SCs,	and	912	veneered	
zirconia	 implant-supported	 SCs.
2. The	overall	incidence	of	biological	and	technical	complication	is	
substantial	 (13%–16%	or	 1	 SC	 out	 of	 6)	 for	 implant	 supported	
SCs.	 This	 statement	 is	 based	 on	 11	 of	 the	 included	 trials	 (6	
Prospective	and	5	Retrospective).
3. There	is	no	statistically	significant	difference	between	the	5-year	
biological	 outcomes	 of	 zirconia	 ceramic	 and	metal	 ceramic	 im-
plant	 supported	 SCs,	 that	 is,	 peri-implant	 mucosal	 lesions	 and	
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marginal	bone	loss	>2	mm.	This	statement	is	based	on	36	clinical	
trials	(22	Prospective	and	14	Retrospective).
4. There	is	no	statistically	significant	difference	in	veneering	ceramic	
chipping	 between	 the	 two	 types	 of	 implant	 supported	 SCs	 at	
5	years.	There	 is	also	no	difference	 in	other	 technical	 complica-
tions	 such	 as	 the	 incidences	of	 fracture	of	 the	 abutment,	 abut-
ment	 screw	 or	 occlusal	 screw	 and	 loss	 of	 retention	 (cemented	
SCs).	 However,	 catastrophic	 core	 fractures	 occur	 significantly	
more	 often	 with	 zirconia	 ceramic	 implant	 supported	 SCs.	
Furthermore,	abutment	screw	or	occlusal	screw	loosening	occurs	
more	frequently	with	metal	ceramic	implant	supported	SCs.	This	
statement	 is	 based	 on	 36	 clinical	 trials	 (22	 Prospective	 and	 14	
Retrospective).
5. The	risk	of	aesthetic	failure	is	lower	for	zirconia	ceramic	SCs	when	
compared	 to	metal	ceramic	SCs.	This	 statement	 is	based	on	12	
clinical	trials	(8	Prospective	and	4	Retrospective).
6.3 | Clinical recommendations
1. For	 anterior	 and	 posterior	 implant	 supported	 SCs,	 both	 metal	
ceramic	 and	 zirconia	 ceramic	 can	 be	 recommended.
2. The	 selection	of	 the	prosthetic	material	 should	be	based	on	
the	 aesthetic	 expectations	 and	 general	 demands	 of	 the	
patients.
3. Patients	should	be	informed	about	the	likelihood	and	incidence	
of	 biological	 and	 technical	 complications	 for	 both	 types	 of	
crowns,	 as	 a	 substantial	 amount	 of	 time	 and	 effort	 may	 be	
needed	for	maintenance.	Patient	recall	visits	are	highly	recom-
mended	 to	 reduce	 the	 risk	 of	 failure	 as	 a	 consequence	 of	
complications.
6.4 | Recommendations for future research
1. Monolithic	 ceramic	 crowns	 or	 micro-veneered	 ceramic	 crowns	
(facial	 veneering	 not	 including	 occlusal/functional	 areas)	 may	
be	 a	 promising	 alternative;	 however,	 scientific	 documentation	
is	 lacking.	 Future	 randomized	 controlled	 clinical	 trials	 should	
address	 the	 survival	 and	 complication	 rates	 of	 these	 more	
recent	 types	 of	 ceramic	 SCs,	 giving	medium-	 to	 long-term	 fol-
low-up	 results.
2. Randomized	comparative	studies	of	different	types	of	monolithic	
ceramic	SCs	(lithium	disilicate,	zirconia,	hybrid	materials)	need	to	
be	performed	giving	medium	to	long-term	follow-up	results.
3. Complications	 should	 be	 reported	 in	 a	 standardized	way,	 using	
established	indices	and	ratings.
4. Fractures	of	ceramic	SCs	should	exclusively	refer	to	catastrophic	
factures	leading	to	the	loss	of	the	entire	prosthesis.
5. Chipping	of	the	ceramic	should	clearly	be	described	as	either:	
a.	 Minor	chipping—polishable
b.	 Major	chipping—repairable
c.	 Catastrophic	 chipping—not	 repairable	 that	 is,	 failure	 of	 the	
prosthesis.
7  | SURVIVAL AND COMPLIC ATION 
R ATES OF ZIRCONIA CER AMIC AND METAL 
CER AMIC MULTIPLE UNIT FDPS
7.1 | Preamble
The	 aim	 of	 this	 systematic	 review	 was	 evaluation	 of	 available	
scientific	evidence	on	the	survival	and	complication	rates	of	ve-
neered	zirconia	ceramic	FDPs	when	compared	to	metal	ceramic	
implant	 supported	 FDPs.	 The	 primary	 outcome	 evaluated	 was	
comparison	 of	 the	 survival	 rates	 of	 the	 veneered	 zirconia	 and	
metal	ceramic	FDPs.	Secondary	outcomes	reviewed	were	biologi-
cal	complication	rates,	technical	complication	rates	and	aesthetic	
failure	rates.
7.2 | Consensus statements
1. Zirconia	 ceramic	 (veneered)	 implant	 supported	 FDPs	 exhibit	
significantly	 lower	 5-year	 survival	 rates	 than	 metal	 ceramic	
implant	supported	FDPs.	This	statement	is	based	on	14	studies	
reporting	 on	 932	 implant-supported	 metal	 ceramic	 FDPs	 (9	
Prospective,	 5	Retrospective)	 and	 three	 studies	 (2	Prospective	
and	 1	 Retrospective)	 reporting	 on	 175	 veneered	 zirconia	 im-
plant-supported	 FDPs.
2. There	is	a	lack	of	detailed	information	in	the	current	literature	to	
provide	a	statement	on	the	biological	and	technical	outcomes	of	
the	zirconia	ceramic	and	metal	ceramic	 implant	supported	FDPs.	
This	statement	is	based	on	the	systematic	review	scrutinizing	the	
available	literature	on	implant	supported	multiple	unit	FDPs.
3. Significantly	more	zirconia	ceramic	implant	supported	FDPs	fail	
due	 to	material	 fracture	 than	metal	 ceramic	 implant	 supported	
FDPs.	This	statement	is	based	on	18	clinical	trials	(11	Prospective	
and	7	Retrospective).
4. Chipping	of	the	veneering	ceramic	is	a	common	technical	compli-
cation	for	both	types	of	FDPs	and	may	lead	to	a	need	for	repair	or	
replacement	of	 the	FDP.	This	 statement	 is	based	on	14	clinical	
trials	(8	Prospective	and	6	Retrospective).
7.3 | Clinical recommendations
1. Zirconia	ceramic	(i.e.,	veneered)	implant	supported	FDPs	cannot	
be	 recommended	 as	 a	 first	 treatment	 option.	 If	 utilized,	 the	
patients	 need	 to	 be	 informed	 about	 the	 risks	 for	 fractures	
of	 the	 framework	 and	 chipping	 of	 the	 veneering	 ceramic.
2. Metal	ceramic,	using	high	noble	(noble	metal	content	>	or	=60%	
and	gold	>	or	=40%)	or	noble	 (noble	metal	content	>	or	=25%)	
alloys,	 should	still	be	considered	as	 the	 first	option	 for	 implant	
supported	FDPs.
3. Due	to	the	high	costs	of	conventional	metal	ceramic	FDPs	and	fre-
quent	 technical	 problems	 associated	 with	 the	 veneered	 FDPs,	
monolithic	 zirconia	 may	 be	 an	 interesting	 alternative.	 However,	
clinical	medium-	to	long-term	outcomes	have	yet	to	be	sufficiently	
analysed.
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7.4 | Recommendations for future research
1. Monolithic	zirconia	implant	supported	FDPs	may	be	a	promising	
alternative;	 however,	 the	 scientific	 documentation	 is	 lacking.	
Future	 prospective	 clinical	 trials	 with	 a	 medium-	 to	 long-term	
follow-up	 should	 address	 the	 survival	 and	 complication	 rates	
of	 the	 monolithic	 zirconia	 FDPs	 in	 general.
2. Comparative	 clinical	 studies	 of	 monolithic	 zirconia	 and	 metal	
ceramic	 implant	 supported	 FDPs	 need	 to	 be	 performed	 before	
clinical	recommendations	can	be	made.
3. New	material	combinations	 including	alternative	metal	or	alloys	
(e.g.,	cobalt	chromium)	or	polymer-based	implant	supported	FDPs	
should	be	considered	in	future	studies.
4. Complications	 should	 be	 reported	 in	 a	 standardized	way,	 using	
established	indices	and	ratings.
5. Fractures	 of	 ceramic	 prostheses	 should	 exclusively	 refer	 to	
catastrophic	fracture	leading	to	loss	of	the	entire	prosthesis.
6. Chipping	 of	 the	 ceramic	 should	 be	 clearly	 described	 as	 either	
minor	 chipping	 (polishable),	 major	 chipping	 (repairable)	 or	
catastrophic	 chipping	 (not	 repairable)	 leading	 to	 failure	 of	 the	
prosthesis.
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